127 related articles for article (PubMed ID: 21878234)
1. Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury.
Zahiri HR; Perrone EE; Strauch ED
Surgery; 2011 Sep; 150(3):480-9. PubMed ID: 21878234
[TBL] [Abstract][Full Text] [Related]
2. Bile salts increase epithelial cell proliferation through HuR-induced c-Myc expression.
Perrone EE; Liu L; Turner DJ; Strauch ED
J Surg Res; 2012 Nov; 178(1):155-64. PubMed ID: 22626558
[TBL] [Abstract][Full Text] [Related]
3. Dietary bile acid supplementation improves intestinal integrity and survival in a murine model.
Perrone EE; Chen C; Longshore SW; Okezie O; Warner BW; Sun CC; Alaish SM; Strauch ED
J Pediatr Surg; 2010 Jun; 45(6):1256-65. PubMed ID: 20620329
[TBL] [Abstract][Full Text] [Related]
4. The bile acid receptor FXR is a modulator of intestinal innate immunity.
Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
[TBL] [Abstract][Full Text] [Related]
5. Bile acid-induced expression of farnesoid X receptor as the basis for superiority of internal biliary drainage in experimental biliary obstruction.
Wu L; Li W; Wang Z; Yuan Z; Hyder Q
Scand J Gastroenterol; 2013 Apr; 48(4):496-503. PubMed ID: 23410061
[TBL] [Abstract][Full Text] [Related]
6. Bile salt stimulates intestinal epithelial cell migration through TGFbeta after wounding.
Strauch ED; Wang JY; Bass BL
J Surg Res; 2001 May; 97(1):49-53. PubMed ID: 11319879
[TBL] [Abstract][Full Text] [Related]
7. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.
Lian F; Xing X; Yuan G; Schäfer C; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP; Burgermeister E
Biochem J; 2011 Sep; 438(2):315-23. PubMed ID: 21619550
[TBL] [Abstract][Full Text] [Related]
9. Taurodeoxycholate increases intestinal epithelial cell proliferation through c-myc expression.
Yamaguchi J; Toledo A; Bass BL; Celeste FA; Rao JN; Wang JY; Strauch ED
Surgery; 2004 Feb; 135(2):215-21. PubMed ID: 14739857
[TBL] [Abstract][Full Text] [Related]
10. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation.
Orazi A; Du X; Yang Z; Kashai M; Williams DA
Lab Invest; 1996 Jul; 75(1):33-42. PubMed ID: 8683938
[TBL] [Abstract][Full Text] [Related]
12. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice.
Martin IV; Schmitt J; Minkenberg A; Mertens JC; Stieger B; Mullhaupt B; Geier A
Biol Chem; 2010 Dec; 391(12):1441-9. PubMed ID: 20868235
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo.
Mroz MS; Keating N; Ward JB; Sarker R; Amu S; Aviello G; Donowitz M; Fallon PG; Keely SJ
Gut; 2014 May; 63(5):808-17. PubMed ID: 23916961
[TBL] [Abstract][Full Text] [Related]
14. Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice.
Méndez-González J; Süren-Castillo S; Calpe-Berdiel L; Rotllan N; Vázquez-Carrera M; Escolà-Gil JC; Blanco-Vaca F
Br J Nutr; 2010 Jan; 103(2):153-60. PubMed ID: 19822032
[TBL] [Abstract][Full Text] [Related]
15. Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice.
Lukovac S; Los EL; Stellaard F; Rings EH; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G520-31. PubMed ID: 19608735
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W
Cancer Res; 2007 Feb; 67(3):863-7. PubMed ID: 17283114
[TBL] [Abstract][Full Text] [Related]
17. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway.
Song M; Ye J; Zhang F; Su H; Yang X; He H; Liu F; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
J Agric Food Chem; 2019 Aug; 67(32):8868-8874. PubMed ID: 31319027
[TBL] [Abstract][Full Text] [Related]
18. Bile salts induce resistance to apoptosis through NF-kappaB-mediated XIAP expression.
Turner DJ; Alaish SM; Zou T; Rao JN; Wang JY; Strauch ED
Ann Surg; 2007 Mar; 245(3):415-25. PubMed ID: 17435549
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells.
Mühlbauer M; Allard B; Bosserhoff AK; Kiessling S; Herfarth H; Rogler G; Schölmerich J; Jobin C; Hellerbrand C
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G1000-8. PubMed ID: 14726307
[TBL] [Abstract][Full Text] [Related]
20. Intestinal bile salt absorption in Atp8b1 deficient mice.
Groen A; Kunne C; Paulusma CC; Kramer W; Agellon LB; Bull LN; Oude Elferink RP
J Hepatol; 2007 Jul; 47(1):114-22. PubMed ID: 17448567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
